Experts discuss the safety profile and cost of gene therapy for the management of sickle cell disease.
John J. Strouse, MD, PhD
Advertisement
Hematologist, Duke Health
Articles by John J. Strouse, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
2
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
3
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
4
CGTLive®’s Weekly Rewind – December 5, 2025
5
